Microsoft Excel LibreOffice Calc

Celgene Corp. (CELG)

Liquidity Analysis

Difficulty: Beginner

  • Annual Data
  • Quarterly Data

    • Liquidity ratios measure the company's ability to meet its short-term obligations.

    Ratios (Summary)

    Celgene Corp., liquidity ratios

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Current ratio 4.99 3.67 4.77 4.60 3.88
    Quick ratio 4.67 3.24 4.05 4.13 3.47
    Cash ratio 4.03 2.69 3.33 3.57 2.92

    Source: Based on data from Celgene Corp. Annual Reports

    Ratio Description The company
    Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Celgene Corp.'s current ratio deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.
    Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Celgene Corp.'s quick ratio deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.
    Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Celgene Corp.'s cash ratio deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.

    Current Ratio

    Celgene Corp., current ratio calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in millions)
    Current assets 14,892  10,868  9,401  9,713  7,551 
    Current liabilities 2,987  2,959  1,969  2,112  1,946 
    Ratio
    Current ratio1 4.99 3.67 4.77 4.60 3.88
    Benchmarks
    Current Ratio, Competitors
    Abbott Laboratories 2.26 4.02 1.54 1.45 2.02
    AbbVie Inc. 1.28 1.65 1.50 1.41 2.59
    Allergan PLC 1.16 2.27 1.03 1.37 1.35
    Amgen Inc. 5.49 4.11 4.44 4.95 3.44
    Biogen Inc. 2.34 2.55 2.60 2.11 1.81
    Bristol-Myers Squibb Co. 1.55 1.55 1.30 1.73 1.52
    Eli Lilly & Co. 1.32 1.37 1.53 1.09 1.47
    Gilead Sciences Inc. 2.74 2.22 2.50 3.07 1.15
    Johnson & Johnson 1.41 2.47 2.17 2.36 2.20
    Merck & Co. Inc. 1.33 1.78 1.55 1.77 2.00
    Pfizer Inc. 1.35 1.25 1.49 2.67 2.41
    Regeneron Pharmaceuticals Inc. 3.82 2.56 3.59 3.31 6.01
    Current Ratio, Sector
    Pharmaceuticals & Biotechnology 1.82 2.14 1.92 2.19 2.13
    Current Ratio, Industry
    Health Care 1.52 1.75 1.65 1.84 1.89

    Source: Based on data from Celgene Corp. Annual Reports

    2017 Calculations

    1 Current ratio = Current assets ÷ Current liabilities
    = 14,892 ÷ 2,987 = 4.99

    Ratio Description The company
    Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Celgene Corp.'s current ratio deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.

    Quick Ratio

    Celgene Corp., quick ratio calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in millions)
    Cash and cash equivalents 7,013  6,170  4,880  4,122  3,234 
    Marketable securities available-for-sale 5,029  1,800  1,672  3,425  2,453 
    Accounts receivable, net of allowances 1,921  1,621  1,421  1,167  1,061 
    Total quick assets 13,963  9,590  7,973  8,713  6,748 
    Current liabilities 2,987  2,959  1,969  2,112  1,946 
    Ratio
    Quick ratio1 4.67 3.24 4.05 4.13 3.47
    Benchmarks
    Quick Ratio, Competitors
    Abbott Laboratories 1.67 3.31 1.04 0.76 1.27
    AbbVie Inc. 0.89 1.14 1.21 1.06 2.00
    Allergan PLC 0.95 2.00 0.42 0.52 0.53
    Amgen Inc. 4.98 3.68 3.97 4.22 2.78
    Biogen Inc. 1.78 1.94 1.93 1.54 1.31
    Bristol-Myers Squibb Co. 1.30 1.27 1.05 1.26 0.61
    Eli Lilly & Co. 0.91 0.98 1.04 0.77 1.06
    Gilead Sciences Inc. 2.52 1.78 2.07 2.56 0.67
    Johnson & Johnson 1.04 2.04 1.77 1.76 1.59
    Merck & Co. Inc. 0.83 1.24 1.04 1.19 1.38
    Pfizer Inc. 0.93 0.84 1.07 2.07 1.79
    Regeneron Pharmaceuticals Inc. 2.98 2.13 3.10 2.93 5.52
    Quick Ratio, Sector
    Pharmaceuticals & Biotechnology 1.42 1.69 1.48 1.63 1.50
    Quick Ratio, Industry
    Health Care 1.18 1.38 1.28 1.38 1.35

    Source: Based on data from Celgene Corp. Annual Reports

    2017 Calculations

    1 Quick ratio = Total quick assets ÷ Current liabilities
    = 13,963 ÷ 2,987 = 4.67

    Ratio Description The company
    Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Celgene Corp.'s quick ratio deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.

    Cash Ratio

    Celgene Corp., cash ratio calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in millions)
    Cash and cash equivalents 7,013  6,170  4,880  4,122  3,234 
    Marketable securities available-for-sale 5,029  1,800  1,672  3,425  2,453 
    Total cash assets 12,042  7,970  6,552  7,547  5,687 
    Current liabilities 2,987  2,959  1,969  2,112  1,946 
    Ratio
    Cash ratio1 4.03 2.69 3.33 3.57 2.92
    Benchmarks
    Cash Ratio, Competitors
    Abbott Laboratories 1.08 2.82 0.67 0.42 0.85
    AbbVie Inc. 0.59 0.66 0.77 0.73 1.44
    Allergan PLC 0.65 1.68 0.13 0.05 0.10
    Amgen Inc. 4.62 3.40 3.62 3.86 2.44
    Biogen Inc. 1.10 1.43 1.33 0.83 0.70
    Bristol-Myers Squibb Co. 0.71 0.72 0.53 0.88 0.36
    Eli Lilly & Co. 0.55 0.55 0.54 0.43 0.61
    Gilead Sciences Inc. 2.19 1.29 1.48 1.76 0.34
    Johnson & Johnson 0.60 1.59 1.38 1.32 1.14
    Merck & Co. Inc. 0.46 0.83 0.70 0.84 0.98
    Pfizer Inc. 0.66 0.57 0.79 1.67 1.39
    Regeneron Pharmaceuticals Inc. 1.24 0.84 1.29 1.38 2.32
    Cash Ratio, Sector
    Pharmaceuticals & Biotechnology 1.03 1.29 1.08 1.21 1.08
    Cash Ratio, Industry
    Health Care 0.80 0.97 0.89 0.98 0.95

    Source: Based on data from Celgene Corp. Annual Reports

    2017 Calculations

    1 Cash ratio = Total cash assets ÷ Current liabilities
    = 12,042 ÷ 2,987 = 4.03

    Ratio Description The company
    Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Celgene Corp.'s cash ratio deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.